Publication | Closed Access

Tailored fluorouracil, epirubicin, and cyclophosphamide compared with marrow-supported high-dose chemotherapy as adjuvant treatment for high-risk breast cancer: a randomised trial

Breast OncologyOncologyHigh-risk Breast CancerRandomised TrialPharmacologyBreast CancerPharmacotherapyTailored FluorouracilCancer TreatmentMedicine